eGenesis
This role involves leading the design, analysis, and interpretation of single-cell RNA-seq and spatial transcriptomics experiments to uncover insights into tissue remodeling and immune responses. The position requires integrating multimodal datasets and developing scalable analytical pipelines to address open biological questions with minimal day-to-day direction. The successful candidate will collaborate with cross-functional teams to translate biological questions into computational analyses and testable hypotheses.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2015
eGenesis is a biotechnology company developing gene-edited organ and cell therapies for transplantation, with a focus on xenotransplantation using engineered pig organs and tissues.
FDA greenlights trial of gene-edited pig kidneys as treatment for end-stage kidney disease
Sep 8, 2025
Scientists Grow More Hopeful About Ending a Global Organ Shortage
Nov 12, 2025
eGenesis Secures IND Clearance for EGEN-2784 in Kidney Transplant and Reports Significant Patient Progress
Sep 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for eGenesis.
eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026
Bioinformatician/Computational Biologist
The Francis Crick Institute
Scientist (Postdoctoral Fellow: Computational Methods for Long Read RNA-Seq data)
ASTARPRD
Bioinformatics & Computational Single-Cell Genomics Expert
mercor
Postdoctoral Fellow, Live Tissue Omics
Biohub
Bioinformatics & Computational Single-Cell Genomics Expert
mercor
Bioinformatics Research Associate
NationalunP2